Sulfaphenazole
Catalog No. A17283
Sulfaphenazole is a specific inhibitor of CYP2C9 which blocks atherogenic and pro-inflammatory effects of linoleic acid (increase in oxidative stress and activation of AP-1) mediated by CYP2C9.
| Catalog Num | A17283 |
|---|---|
| M. Wt | 314.363 |
| Formula | C15H14N4O2S |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 526-08-9 |
| Synonyms | BRN-0308518; BRN0308518; BRN 0308518; Sulfaphenazole; Firmazolo; Inamil |
| SMILES | O=S(NC1=CC=NN1C2=CC=CC=C2)(C3=CC=C(N)C=C3)=O |
Sulfaphenazole is a specific inhibitor of CYP2C9 which blocks atherogenic and pro-inflammatory effects of linoleic acid (increase in oxidative stress and activation of AP-1) mediated by CYP2C9.
| In vitro | DMSO | 53 mg/mL (168.59 mM) | |
| Water | Insoluble | ||
| Ethanol | 53 mg/mL | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 31.81 mL | 159.05 mL | 318.1 mL |
| 0.5 mM | 6.36 mL | 31.81 mL | 63.62 mL |
| 1 mM | 3.18 mL | 15.91 mL | 31.81 mL |
| 5 mM | 0.64 mL | 3.18 mL | 6.36 mL |
*The above data is based on the productmolecular weight 314.363. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.